无症状癌症患者的热素升高:揭示联系和临床影响
Sebastian W Romann1,2, Evangelos Giannitsis1,2, Norbert Frey1,2
1Department of Internal Medicine III: Cardiology, Angiology & Pulmonology, Cardio-Oncology Unit, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
Current heart failure reports
|September 10, 2024
概括
无症状癌症患者心脏托罗邦素的升高是复杂的. 本次审查强调了它们对死亡率和心脏毒性的预测价值,有助于在癌症治疗前进行风险评估.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 生物标志物研究 生物标志物研究
背景情况:
- 升高的托罗邦素水平是诊断症状个体急性冠状动脉综合征的标准.
- 无症状癌症患者的热激素升高存在诊断挑战,与传统的心脏事件关联有所不同.
研究的目的:
- 审查当前关于心脏托波尼因在预测和识别高风险癌症患者的文献.
- 专注于诊断挑战,生物标志物的意义,以及有关瘤学中热素的知识差距.
主要方法:
- 关于癌症患者心脏热素的最新出版物的文献综述.
- 对诊断挑战和生物标志物的重要性进行分析.
主要成果:
- 心脏生物标志物,包括热波宁,预测癌症患者的全因死亡率和心脏毒性.
- 在癌症治疗前进行风险分析时,心脏类素是重要的.
- 热素可以作为进一步的心脏评估和治疗的诊断门卫.
结论:
- 心脏中热素水平为癌症患者的结果提供了显著的预测价值.
- 了解无症状癌症患者的热素对于风险分层和管理至关重要.
- 需要进一步的研究来解决这个复杂领域的知识差距.
更多相关视频
04:40Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
Published on: January 5, 2024
2.2K
07:40Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
Published on: October 10, 2019
7.3K
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
110
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
110
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
